Search
Congressman Jake Auchincloss discusses the economic impact of biotech, global competition, and efforts he is taking to solidify funding, modernize regulation, and keep the United States on top
Interviewed by MassBio CEO Kendalle Burlin O'Connell, Congressman Auchincloss of Massachusetts describes the impact he believes a tightening of funding for basic research is having on our industry and measures he would take to bolster innovative research. He advocates for making it easier to run early stage clinical trials in the U.S. and for it to be less costly for small biotech companies to engage with FDA. Chapters The economic impact of biotech - 1:28 Global competition
Sep 2
Two fathers of children with rare diseases talk about starting biotech companies to try to create new therapies for their family members and others
Interviewed by MassBio CEO Kendalle Burlin O'Connell, Ilan Ganot describes co-founding Solid Biosciences in honor of his child with Duchenne muscular dystrophy and Daniel Fischer discusses co-founding Tevard Biosciences in honor of his child with Dravet syndrome. Chapters Intros - 1:11 Ilan Ganot | Starting a DMD company - 6:17 Daniel Fischer | Starting a Dravet company - 8:39 The Massachusetts ecosystem - 10:36 Being a CEO - 18:48 Advice for other parents - 23:43 Incentivizi
Aug 26
MassBio's 2026 Industry Snapshot shows a biotech sector that has been accelerating this year, but warning signs about early stage company building and investments should be given close attention
MassBio CEO Kendalle Burlin O'Connell highlights key findings of the report, including that employment in life sciences was down in 2025 for the first time in decades, and suggests that we should be both optimistic about the current state of the sector but mindful to make seed investments to keep it up over the longer term. Download the Report
Aug 25
U.S. Science Summit: Three leading biotech CEOs share the latest on biotech innovation and discuss how the United States can stay on top of an increasingly competitive global landscape
Moderated by MassBio CEO Kendalle Burlin O'Connell, Kymera Therapeutics CEO Nello Mainolfi, CRISPR Therapeutics CEO Samarth Kulkarni, and Ginkgo Bioworks CEO Jason Kelly discuss their companies' innovations (protein degradation, CRISPR gene editing, and autonomous labs), how the U.S. can increase its competitiveness, and the 'Why' that motivates them each day.
Jul 20
U.S. Science Summit: MassBio President & CEO Kendalle Burlin O'Connell welcomes the audience to the inaugural U.S. Science Summit
She explains how biotech was founded in Massachusetts and how this is the place where patients come for hope.
Jul 20
Biotech CEOs discuss the importance of culture, getting through challenging times, their policy wishlist, and how they are proud of the ways our industry gives back
MassBio President & CEO Kendalle Burlin O'Connell moderates a discussion with Zag Bio CEO Jason Cole and Altido Therapeutics CEO Chip Clark about running early stage companies and what advice they have for new CEOs. They offer advice about what it will take to keep our ecosystem globally competitive. Chapters Zag Bio - 1:03 Altido Therapeutics - 2:12 Massachusetts - 3:00 Culture- 5:11 Different skill sets - 7:11 Getting through challenge - 9:12 Early stage companies - 15:27 F
Mar 20
Biotech CEOs discuss the state of the industry, what is needed to compete globally, the importance of having a patient-centric approach, and more
MassBio President & CEO Kendalle Burlin O'Connell moderates a discussion with Aurora Therapeutics CEO Ed Kaye and DaCapo Brainscience CEO Leslie Williams about being biotech leaders during this volatile time for the industry. They stress that a key to success is that everyone in the industry work together towards shared goals. Chapters Introductions - 1:19 Aurora Therapeutics - 5:34 DaCapo Brainscience - 9:37 Being patient centric - 11:00 The state of the industry - 19:04 Mas
Feb 12
Biotech entrepreneurs share advice on navigating through today's uncertain times: "It's going to be okay"
MassBio CEO Kendalle Burlin O'Connell moderates a discussion with Normunity CEO Rachel Humphrey and Gallop Oncology CEO Luba Greenwood about how they are rising to today's challenges. Topics include the funding environment, motivating your team, storytelling, FDA engagement, and perseverance. Chapters Intro's – 0:52 The funding environment - 2:51 Motivating your team – 17:20 Storytelling – 28:17 Engagement with FDA – 39:51 Perseverance – 42:23 Advice for new entrepreneurs – 4
Oct 22, 2025
MassBio's CEO Kendalle Burlin O'Connell shares the details of today's just published 2025 Industry Snapshot - a key barometer of the health of biotech not just in Massachusetts, but as an industry
She discusses the report and specifics on NIH funding, VC investment, jobs, biotech clusters within Massachusetts, and more. VIEW THE...
Aug 26, 2025
Biotech Direct: MassBio CEO Kendalle Burlin O'Connell and Seaport Therapeutics Founder & CEO Daphne Zohar discuss NIH funding, recent developments at FDA, and improving the public's view of science
In this inaugural episode of Biotech Direct, BiotechTV's new show that will share the biotech industry's perspective on policy and...
Aug 15, 2025
MassBio's CEO on the Align Summit and supporting the innovation ecosystem in Massachusetts
Kendalle Burlin O'Connell describes the goals of the Align Summit and the work MassBio is doing.
Apr 25, 2024
.png){kind=logo}